Search

CHECT calls on practices to join in World Retinoblastoma Awareness Week

The charity is encouraging optometry practices to support the campaign, which takes place 10–16 May

An infant sitting in a pushchair looks at the camera. The camera flash reflects red in one eye, and white in the other, a sign of potential retinoblastoma
CHECT

The Childhood Eye Cancer Trust (CHECT) has encouraged optometry practices in the UK to participate in World Retinoblastoma Awareness Week, which takes place 10–16 May.

The charity highlighted that optometrists are often among the first professionals able to spot early signs of retinoblastoma, as routine eye exams can reveal leukocoria or a squint, which might otherwise go unnoticed by parents.

By promoting awareness and sharing information, optical practices can help to ensure more children receive timely diagnosis and treatment, CHECT has said.

The organisation has created a resource kit with pre-written social media content, images and graphics, awareness messaging guidance, as well as printable posters and educational materials. Free signs and symptoms leaflets and posters can be requested from CHECT to display in the practice.

Practices can also support the campaign by liking and sharing content from CHECT across social media or posting content using the hashtag #RbWeek.

CHECT has also suggested a number of activities practices could engage in to help raise awareness and funds for the charity.

These include hosting a ‘Crazy Glasses Day,’ with a free downloadable glasses template available from the charity, or holding fundraising events at the practice, such as a coffee morning or bake sale.

Individuals can also participate in one of CHECT’s organised events, such as the Great North Run, the National 3 Peaks Challenge, or a tandem skydive.

CHECT’s fundraising manager, Priyanka Kotecha, can be contacted to discuss support, ideas, and resources.

The charity shared: “By taking part in World Retinoblastoma Awareness Week 2026, your optical practice can play a vital role in raising public understanding, improving early diagnosis, and supporting children and families affected by this rare cancer.”